Ara
Toplam kayıt 11, listelenen: 1-10
High Prevalence Of Esbl-Producing Escherichia Coli And Klebsiella Pneumoniae In Community-Onset Bloodstream Infections In China
(Oxford Univ Press, 2017)
Objectives: Community-onset bloodstream infections (COBSIs) caused by ESBL-producing Escherichia coli (ESBLEC) and ESBL-producing Klebsiella pneumoniae (ESBL-KP) are increasing globally. This study aimed to investigate the ...
Efficacy Of Beta-Lactam/Beta-Lactamase Inhibitor Combinations For The Treatment Of Bloodstream Infection Due To Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae In Hematological Patients With Neutropenia
(Amer Soc Microbiology, 2017)
beta-Lactam/beta-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum beta-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy ...
A Multinational, Preregistered Cohort Study Of Beta-Lactam/Beta-Lactamase Inhibitor Combinations For Treatment Of Bloodstream Infections Due To Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae
(Amer Soc Microbiology, 2016)
The spread of extended-spectrum-beta-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is leading to increased carbapenem consumption. Alternatives to carbapenems need to be investigated. We investigated whether ...
A Multidisciplinary Team Approach to the Management of Patients with Suspected or Diagnosed Invasive Fungal Disease
(Oxford Univ Press, 2013)
Implementation of evidence-based guidelines for the treatment of invasive fungal disease (IFD) requires collaboration among numerous clinical and laboratory services, as partners in patient care. The multidisciplinary team ...
Risk Assessment and Prognostic Factors For Mould-Related Diseases in Immunocompromised Patients
(Oxford Univ Press, 2011)
Invasive fungal diseases are important causes of morbidity and mortality in immunocompromised patients. Patients with haematological malignancies and solid cancers, as well as those with allogeneic haematopoietic stem cell ...
Clinical Experience Of Colistin-Glycopeptide Combination In Critically Ill Patients Infected With Gram-Negative Bacteria
(Amer Soc Microbiology, 2014)
A colistin-glycopeptide combination (CGC) has been shown in vitro to be synergistic against multidrug-resistant Gram-negative bacteria (MDR GNB), especially Acinetobacter baumannii, and to prevent further resistance. ...
Development And Validation Of The Increment-Esbl Predictive Score For Mortality In Patients With Bloodstream Infections Due To Extendedspectrum- Beta-Lactamase-Producing Enterobacteriaceae
(Oxford Univ Press, 2017)
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a ...
Epidemiology Of Antimicrobial Resistance In Bloodstream Infections
(Taylor & Francis Inc, 2016)
Antimicrobial resistance in bacterial pathogens is a worldwide challenge leading high morbidity and mortality in clinical settings. Multidrug resistant patterns in gram-positive and -negative bacteria have resulted in ...
Ertapenem For The Treatment Of Bloodstream Infections Due To Esbl-Producing Enterobacteriaceae: A Multinational Pre-Registered Cohort Study
(Oxford Univ Press, 2016)
Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other ...
Dali: Defining Antibiotic Levels In Intensive Care Unit Patients: Are Current Beta-Lactam Antibiotic Doses Sufficient For Critically Ill Patients?
(Oxford Univ Press, 2014)
Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether beta-lactam antibiotic dosing in critically ill patients achieves concentrations ...